Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 4 studies | 24% ± 3% | |
epithelial cell | 4 studies | 35% ± 10% | |
basal cell | 4 studies | 26% ± 6% | |
ciliated cell | 4 studies | 22% ± 2% | |
squamous epithelial cell | 3 studies | 37% ± 25% | |
enterocyte | 3 studies | 24% ± 3% |
Insufficient scRNA-seq data for expression of INAVA at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 88% | 858.34 | 289 / 328 | 93% | 47.34 | 166 / 178 |
kidney | 99% | 1636.03 | 88 / 89 | 68% | 11.38 | 614 / 901 |
stomach | 64% | 1102.73 | 229 / 359 | 97% | 56.08 | 278 / 286 |
intestine | 47% | 2325.47 | 450 / 966 | 98% | 48.66 | 517 / 527 |
bladder | 48% | 1299.48 | 10 / 21 | 92% | 34.10 | 463 / 504 |
esophagus | 39% | 1703.37 | 558 / 1445 | 99% | 67.47 | 181 / 183 |
lung | 38% | 216.67 | 218 / 578 | 93% | 31.06 | 1075 / 1155 |
ureter | 0% | 0 | 0 / 0 | 100% | 41.87 | 1 / 1 |
ovary | 0% | 0 | 0 / 180 | 96% | 34.96 | 412 / 430 |
tonsil | 0% | 0 | 0 / 0 | 96% | 33.89 | 43 / 45 |
uterus | 4% | 50.92 | 6 / 170 | 85% | 33.14 | 391 / 459 |
prostate | 71% | 792.21 | 175 / 245 | 12% | 1.26 | 62 / 502 |
skin | 72% | 3681.14 | 1300 / 1809 | 8% | 1.15 | 37 / 472 |
breast | 6% | 38.50 | 28 / 459 | 35% | 6.73 | 387 / 1118 |
brain | 0% | 1.89 | 12 / 2642 | 35% | 4.05 | 249 / 705 |
liver | 0% | 0 | 0 / 226 | 26% | 6.44 | 106 / 406 |
thymus | 0% | 0 | 0 / 653 | 18% | 2.21 | 110 / 605 |
peripheral blood | 16% | 306.49 | 152 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 4.47 | 7 / 1335 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0 | 0 / 258 | 0% | 0.07 | 1 / 230 |
adipose | 0% | 4.59 | 4 / 1204 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.83 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
heart | 0% | 0 | 0 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
GO_0002221 | Biological process | pattern recognition receptor signaling pathway |
GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
GO_0034334 | Biological process | adherens junction maintenance |
GO_0045087 | Biological process | innate immune response |
GO_0002720 | Biological process | positive regulation of cytokine production involved in immune response |
GO_0032495 | Biological process | response to muramyl dipeptide |
GO_0032733 | Biological process | positive regulation of interleukin-10 production |
GO_0043410 | Biological process | positive regulation of MAPK cascade |
GO_0032494 | Biological process | response to peptidoglycan |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_1903409 | Biological process | reactive oxygen species biosynthetic process |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0070431 | Biological process | nucleotide-binding oligomerization domain containing 2 signaling pathway |
GO_0031398 | Biological process | positive regulation of protein ubiquitination |
GO_0060729 | Biological process | intestinal epithelial structure maintenance |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0005515 | Molecular function | protein binding |
Gene name | INAVA |
Protein name | Alternative protein C1orf106 Innate immunity activator Innate immunity activator protein |
Synonyms | C1orf106 |
Description | FUNCTION: Expressed in peripheral macrophages and intestinal myeloid-derived cells, is required for optimal PRR (pattern recognition receptor)-induced signaling, cytokine secretion, and bacterial clearance. Upon stimulation of a broad range of PRRs (pattern recognition receptor) such as NOD2 or TLR2, TLR3, TLR4, TLR5, TLR7 and TLR9, associates with YWHAQ/14-3-3T, which in turn leads to the recruitment and activation of MAP kinases and NF-kappa-B signaling complexes that amplifies PRR-induced downstream signals and cytokine secretion . In the intestine, regulates adherens junction stability by regulating the degradation of CYTH1 and CYTH2, probably acting as substrate cofactor for SCF E3 ubiquitin-protein ligase complexes. Stabilizes adherens junctions by limiting CYTH1-dependent ARF6 activation . . |
Accessions | ENST00000532631.5 Q3KP66 A0A8V8N8P9 C9JAT8 ENST00000413687.3 [Q3KP66-3] ENST00000367342.8 ENST00000451872.6 L8E8V8 E9PK29 |